BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33137182)

  • 1. ADPriboDB 2.0: an updated database of ADP-ribosylated proteins.
    Ayyappan V; Wat R; Barber C; Vivelo CA; Gauch K; Visanpattanasin P; Cook G; Sazeides C; Leung AKL
    Nucleic Acids Res; 2021 Jan; 49(D1):D261-D265. PubMed ID: 33137182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADPriboDB v2.0: An Updated Database of ADP-ribosylated Proteins.
    Ayyappan V; Wat R; Barber C; Vivelo CA; Gauch K; Visanpattanasin P; Cook G; Sazeides C; Leung AKL
    bioRxiv; 2020 Sep; ():. PubMed ID: 32995784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADPriboDB: The database of ADP-ribosylated proteins.
    Vivelo CA; Wat R; Agrawal C; Tee HY; Leung AK
    Nucleic Acids Res; 2017 Jan; 45(D1):D204-D209. PubMed ID: 27507885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral Macro Domains Reverse Protein ADP-Ribosylation.
    Li C; Debing Y; Jankevicius G; Neyts J; Ahel I; Coutard B; Canard B
    J Virol; 2016 Oct; 90(19):8478-86. PubMed ID: 27440879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrolysis of ADP-Ribosylation by Macrodomains.
    Posavec Marjanovic M; Jankevicius G; Ahel I
    Methods Mol Biol; 2018; 1813():215-223. PubMed ID: 30097870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering Af1521 improves ADP-ribose binding and identification of ADP-ribosylated proteins.
    Nowak K; Rosenthal F; Karlberg T; Bütepage M; Thorsell AG; Dreier B; Grossmann J; Sobek J; Imhof R; Lüscher B; Schüler H; Plückthun A; Leslie Pedrioli DM; Hottiger MO
    Nat Commun; 2020 Oct; 11(1):5199. PubMed ID: 33060572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase.
    Alhammad YMO; Kashipathy MM; Roy A; Gagné JP; McDonald P; Gao P; Nonfoux L; Battaile KP; Johnson DK; Holmstrom ED; Poirier GG; Lovell S; Fehr AR
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33158944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gas-Phase Fragmentation of ADP-Ribosylated Peptides: Arginine-Specific Side-Chain Losses and Their Implication in Database Searches.
    Gehrig PM; Nowak K; Panse C; Leutert M; Grossmann J; Schlapbach R; Hottiger MO
    J Am Soc Mass Spectrom; 2021 Jan; 32(1):157-168. PubMed ID: 33140951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADP-ribosylhydrolases: from DNA damage repair to COVID-19.
    Yu L; Liu X; Yu X
    J Zhejiang Univ Sci B; 2021 Jan; 22(1):21-30. PubMed ID: 33448184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARPs and ADP-ribosylation: Deciphering the complexity with molecular tools.
    Dasovich M; Leung AKL
    Mol Cell; 2023 May; 83(10):1552-1572. PubMed ID: 37119811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical ADP-ribosylation: mono-ADPr-peptides and oligo-ADP-ribose.
    Liu Q; van der Marel GA; Filippov DV
    Org Biomol Chem; 2019 Jun; 17(22):5460-5474. PubMed ID: 31112180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role of intracellular mono-ADP-ribosylation in cancer biology.
    Scarpa ES; Fabrizio G; Di Girolamo M
    FEBS J; 2013 Aug; 280(15):3551-62. PubMed ID: 23590234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling.
    Russo LC; Tomasin R; Matos IA; Manucci AC; Sowa ST; Dale K; Caldecott KW; Lehtiö L; Schechtman D; Meotti FC; Bruni-Cardoso A; Hoch NC
    J Biol Chem; 2021 Sep; 297(3):101041. PubMed ID: 34358560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a Mass-Spectrometry-Based Method for the Identification of the
    Lüthi SC; Howald A; Nowak K; Graage R; Bartolomei G; Neupert C; Sidler X; Leslie Pedrioli D; Hottiger MO
    J Proteome Res; 2021 Jun; 20(6):3090-3101. PubMed ID: 34032442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A family of macrodomain proteins reverses cellular mono-ADP-ribosylation.
    Jankevicius G; Hassler M; Golia B; Rybin V; Zacharias M; Timinszky G; Ladurner AG
    Nat Struct Mol Biol; 2013 Apr; 20(4):508-14. PubMed ID: 23474712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host ADP-ribosylation and the SARS-CoV-2 macrodomain.
    Hoch NC
    Biochem Soc Trans; 2021 Aug; 49(4):1711-1721. PubMed ID: 34351418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legionella metaeffector MavL reverses ubiquitin ADP-ribosylation via a conserved arginine-specific macrodomain.
    Zhang Z; Fu J; Rack JGM; Li C; Voorneveld J; Filippov DV; Ahel I; Luo ZQ; Das C
    Nat Commun; 2024 Mar; 15(1):2452. PubMed ID: 38503748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Players in ADP-ribosylation: Readers and Erasers.
    Verheugd P; Bütepage M; Eckei L; Lüscher B
    Curr Protein Pept Sci; 2016; 17(7):654-667. PubMed ID: 27090904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral macrodomains: a structural and evolutionary assessment of the pharmacological potential.
    Rack JGM; Zorzini V; Zhu Z; Schuller M; Ahel D; Ahel I
    Open Biol; 2020 Nov; 10(11):200237. PubMed ID: 33202171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Techniques for ADP-Ribosylated Substrate Identification.
    Grimaldi G; Catara G; Valente C; Corda D
    Methods Mol Biol; 2018; 1813():25-40. PubMed ID: 30097859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.